The Latest Breaking News from FDA

The documentary Plan C embeds with the organization sending FDA-approved abortion pills to recipients in all 50 states

Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.

The facts alone make for compelling viewing, but without access to all the main players it feels incomplete

Trish Webster lost 16 kilograms but the consequences were allegedly lethal

A new study finds that hormonal contraceptive pills may affect parts of the brain that deal with fear.

Policies inspired by that exaggerated threat continue to undermine the harm-reducing potential of e-cigarettes.

The ongoing investigation now entails reports of seven "adverse events" that took place from Oct. 17 through Nov. 1

Biotech major Biogen (BIIB) will report its third-quarter results on November 8. Its EPS and revenue are expected to decline year-over-year. However, the FDA approvals for new drugs received by the company this year will likely support its long-term growth. Let’s discuss the potential road ahead for the stock….

More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies